Literature DB >> 16054440

Ketogenic diet decreases circulating concentrations of neuroactive steroids of female rats.

Madeline E Rhodes1, Jayanth Talluri, Jacob P Harney, Cheryl A Frye.   

Abstract

Ketogenic diet (KD) is used to manage intractable epilepsy; however, the mechanisms underlying its therapeutic effects are not known. Steroid hormones, such as progesterone and testosterone, are derived from cholesterol, and are readily 5alpha-reduced to dihydroprogesterone and dihydrotestosterone, which are subsequently converted to 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP) and 3alpha-androstanediol, neuroactive steroids that can influence seizures. The present study examined the effects of the KD on circulating concentrations of these neuroactive steroids, and their precursors, in intact female rats. Thirty-six, 22-day-old female Sprague-Dawley rats (weaned at 21 days) were fasted for 8 hours prior to placement on one of three dietary regimens for 6 weeks: ad libitum chow, calorie-restricted chow, or KD. After 6 weeks of the diet, when six rats in each dietary condition were in diestrus and six were in behavioral estrus, all rats were administered pentylenetetrazole (PTZ, 70 mg/kg, i.p.). The latency and incidence of seizures were recorded by an observer who was uninformed of the estrous cycle and dietary treatment conditions of the rats. Immediately after each test, trunk blood was obtained for later measurement of pregnane (progesterone, dihydroprogesterone, 3alpha,5alpha-THP) and androstane (testosterone, dihydrotestosterone, 3alpha-androstanediol) neuroactive steroid concentrations in plasma by radioimmunoassay. KD tended to lengthen the latency to, and significantly reduced the number of, PTZ-induced barrel roll seizures. KD also significantly reduced plasma levels of the pregnane (dihydroprogesterone, 3alpha,5alpha-THP) and androstane (dihydrotestosterone, 3alpha-androstanediol) 5alpha-reduced metabolites. These data suggest that levels of pregnane and androstane neuroactive steroids, or their precursors, may underlie some of the antiseizure effects of KD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054440      PMCID: PMC3637968          DOI: 10.1016/j.yebeh.2005.05.025

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  78 in total

1.  The antidepressant properties of the ketogenic diet.

Authors:  Patricia Murphy; Sergei Likhodii; Kirk Nylen; W M Burnham
Journal:  Biol Psychiatry       Date:  2004-12-15       Impact factor: 13.382

Review 2.  3alpha-hydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors.

Authors:  C A Frye; M E Rhodes; S M Petralia; A A Walf; K Sumida; K L Edinger
Journal:  Neuroscience       Date:  2005-12-01       Impact factor: 3.590

3.  The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively.

Authors:  C Hemingway; J M Freeman; D J Pillas; P L Pyzik
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

Review 4.  A comparison of drug treatment versus electrical stimulation for suppressing seizure activity.

Authors:  Benedict C Albensi
Journal:  Drug News Perspect       Date:  2003 Jul-Aug

Review 5.  Androgens in the hippocampus can alter, and be altered by, ictal activity.

Authors:  Madeline E Rhodes; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2004-07       Impact factor: 3.533

Review 6.  The ketogenic diet for the treatment of epilepsy: a challenge for nutritional neuroscientists.

Authors:  Carl E Stafstrom; Kristopher J Bough
Journal:  Nutr Neurosci       Date:  2003-04       Impact factor: 4.994

Review 7.  Reproductive endocrine considerations and hormonal therapy for women with epilepsy.

Authors:  A G Herzog
Journal:  Epilepsia       Date:  1991       Impact factor: 5.864

8.  Seizure activity is increased in endocrine states characterized by decline in endogenous levels of the neurosteroid 3 alpha,5 alpha-THP.

Authors:  C A Frye; L E Bayon
Journal:  Neuroendocrinology       Date:  1998-10       Impact factor: 4.914

9.  The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy.

Authors:  C A Frye
Journal:  Brain Res       Date:  1995-10-23       Impact factor: 3.252

Review 10.  Therapeutics in pediatric epilepsy, Part 1: The new antiepileptic drugs and the ketogenic diet.

Authors:  Randa G Jarrar; Jeffrey R Buchhalter
Journal:  Mayo Clin Proc       Date:  2003-03       Impact factor: 7.616

View more
  3 in total

Review 1.  State of the ketogenic diet(s) in epilepsy.

Authors:  Jennifer Huffman; Eric H Kossoff
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 2.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

Review 3.  The Influence of Ketone Bodies on Circadian Processes Regarding Appetite, Sleep and Hormone Release: A Systematic Review of the Literature.

Authors:  Davide Masi; Maria Elena Spoltore; Rebecca Rossetti; Mikiko Watanabe; Rossella Tozzi; Alessandra Caputi; Renata Risi; Angela Balena; Orietta Gandini; Stefania Mariani; Giovanni Spera; Lucio Gnessi; Carla Lubrano
Journal:  Nutrients       Date:  2022-03-28       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.